Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NEXIUM | AstraZeneca | N-021153 RX | 2001-02-20 | 2 products, RLD, RS |
NEXIUM | AstraZeneca | N-021957 RX | 2006-10-20 | 4 products, RLD, RS |
NEXIUM | AstraZeneca | N-022101 RX | 2008-02-27 | 1 products, RLD |
NEXIUM 24HR | AstraZeneca | N-204655 OTC | 2014-03-28 | 1 products, RLD, RS |
NEXIUM 24HR | AstraZeneca | N-207920 OTC | 2015-11-23 | 1 products, RLD, RS |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VIMOVO | Horizon Pharmaceutical | N-022511 DISCN | 2010-04-30 | 2 products, RLD |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
NEXIUM IV | AstraZeneca | N-021689 RX | 2005-03-31 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
acid reducer | ANDA | 2023-10-25 |
basic care esomeprazole magnesium | ANDA | 2020-08-19 |
basic care omeprazole and sodium bicarbonate | ANDA | 2021-07-22 |
berkley and jensen heartburn treatment | ANDA | 2020-01-29 |
careone esomeprazole magnesium | ANDA | 2019-12-18 |
dg health esomeprazole magnesium | ANDA | 2021-12-09 |
equate omeprazole and sodium bicarbonate | ANDA | 2021-05-04 |
esomeprazole | ANDA | 2023-11-03 |
esomeprazole dr | ANDA | 2023-08-23 |
esomeprazole magnesium | ANDA | 2024-01-18 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 8 | 17 | 23 | 33 | 19 | 97 |
Infections | D007239 | EFO_0000544 | — | 1 | 1 | 3 | 43 | 21 | 69 |
Healthy volunteers/patients | — | — | — | 43 | 1 | 1 | 6 | 1 | 51 |
Dyspepsia | D004415 | EFO_0008533 | K30 | 3 | 6 | 4 | 12 | 1 | 24 |
Stomach ulcer | D013276 | — | K25 | 1 | — | 13 | 2 | 5 | 21 |
Gastritis | D005756 | EFO_0000217 | K29.7 | 2 | 1 | 3 | 8 | 4 | 18 |
Peptic ulcer | D010437 | HP_0004398 | K27 | 3 | 1 | 2 | 9 | 1 | 16 |
Esophagitis | D004941 | HP_0100633 | K20 | 1 | 2 | 7 | 5 | 1 | 16 |
Heartburn | D006356 | — | R12 | 1 | 1 | 3 | 7 | 1 | 12 |
Peptic esophagitis | D004942 | EFO_1001095 | — | 1 | 2 | 4 | 2 | 2 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Duodenal ulcer | D004381 | EFO_0004607 | K26 | 1 | — | 4 | — | 5 | 10 |
Arthritis | D001168 | HP_0001369 | M05-M14 | 4 | — | 2 | — | — | 6 |
Pre-eclampsia | D011225 | EFO_0000668 | O14 | 1 | 1 | 2 | — | 2 | 5 |
Gastrointestinal diseases | D005767 | — | — | 1 | — | 2 | — | 2 | 5 |
Non-erosive reflux disease | D000096663 | — | — | — | 1 | 1 | — | 2 | 4 |
Asthma | D001249 | EFO_0000270 | J45 | — | 2 | 1 | — | — | 3 |
Gastrointestinal hemorrhage | D006471 | HP_0002239 | K92.2 | — | 1 | 2 | — | — | 3 |
Eosinophilic esophagitis | D057765 | EFO_0004232 | K20.0 | — | 1 | 1 | — | 1 | 2 |
Esophageal neoplasms | D004938 | — | C15 | — | 1 | 1 | — | — | 2 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | 1 | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | — | 2 |
Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | 1 | 1 | — | — | — | 2 |
Replacement arthroplasty knee | D019645 | — | — | — | 1 | — | — | — | 1 |
Neuralgia | D009437 | EFO_0009430 | — | — | 1 | — | — | — | 1 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 1 | — | — | — | 1 |
Heart valve diseases | D006349 | EFO_0009551 | I08 | — | 1 | — | — | — | 1 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | — | 1 | — | — | — | 1 |
Autistic disorder | D001321 | HP_0000717 | F84.0 | — | 1 | — | — | — | 1 |
Deglutition disorders | D003680 | HP_0002015 | R13.1 | — | 1 | — | — | — | 1 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pharmacokinetics | D010599 | — | — | 4 | — | — | — | 1 | 5 |
Therapeutic equivalency | D013810 | — | — | 4 | — | — | — | — | 4 |
Chronic hepatitis b | D019694 | EFO_0004239 | B18.1 | 2 | — | — | — | — | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | 1 | — | — | — | — | 1 |
Pulmonary arterial hypertension | D000081029 | — | — | 1 | — | — | — | — | 1 |
Sickle cell anemia | D000755 | EFO_0000697 | D57 | 1 | — | — | — | — | 1 |
Lymphoma | D008223 | — | C85.9 | 1 | — | — | — | — | 1 |
Homeostasis | D006706 | — | — | 1 | — | — | — | — | 1 |
Chronic pancreatitis | D050500 | EFO_0000342 | K86.1 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Drug-related side effects and adverse reactions | D064420 | — | T88.7 | — | — | — | — | 2 | 2 |
Drug interactions | D004347 | — | — | — | — | — | — | 1 | 1 |
Pyloromyotomy | D000074882 | — | — | — | — | — | — | 1 | 1 |
Calcium metabolism disorders | D002128 | EFO_0005769 | E83.5 | — | — | — | — | 1 | 1 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Radiotherapy | D011878 | — | — | — | — | — | — | 1 | 1 |
Mortality | D009026 | EFO_0004352 | — | — | — | — | — | 1 | 1 |
Hemostasis | D006487 | — | — | — | — | — | — | 1 | 1 |
Sudden death cardiac | D016757 | EFO_0004278 | — | — | — | — | — | 1 | 1 |
Thrombocytopenic purpura idiopathic | D016553 | EFO_0007160 | D69.3 | — | — | — | — | 1 | 1 |
Drug common name | Esomeprazole |
INN | esomeprazole |
Description | (R)-omeprazole is a 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole that has R configuration at the sulfur atom. It is an enantiomer of an esomeprazole. |
Classification | Small molecule |
Drug class | antiulcer agents (benzimidazole derivatives) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1ccc2[nH]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1 |
PDB | — |
CAS-ID | 119141-88-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1201320 |
ChEBI ID | 50275 |
PubChem CID | 9579578 |
DrugBank | DB00736 |
UNII ID | N3PA6559FT (ChemIDplus, GSRS) |